Ownership Submission
FORM 4
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Expires: January 31, 2005
Estimated average burden hours per response... 0.5

(Print or Type Responses)
1. Name and Address of Reporting Person *
INVEMED CATALYST FUND LP
  2. Issuer Name and Ticker or Trading Symbol
WORLD WRESTLING ENTERTAINMENTINC [WWE]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director __X__ 10% Owner
_____ Officer (give title below) __X__ Other (specify below)
See Remarks
(Last)
(First)
(Middle)
375 PARK AVE, STE 2205
3. Date of Earliest Transaction (Month/Day/Year)
11/20/2009
(Street)

NEW YORK, NY 10152
4. If Amendment, Date Original Filed(Month/Day/Year)
6. Individual or Joint/Group Filing(Check Applicable Line)
___ Form filed by One Reporting Person
_X_ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4)
7. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V Amount (A) or (D) Price
Class A Common Share, $0.01 per share 11/20/2009   J   1,291,346 D (1) 1,291,427 D (1)  
Class A Common Share, $0.01 per share 11/20/2009   J   1,291,346 D (1) 1,291,427 I (1) (2) Held by Invemed Catalyst Fund, L.P.
Class A Common Share, $0.01 per share 11/20/2009   J   1,285,688 D (1) 1,291,427 I (1) (3) Held by Invemed Catalyst Fund, L.P.
Class A Common Share, $0.01 per share               5,658 D (3)  
Class A Common Share, $0.01 per share 11/20/2009   J   1,241,122 D (1) 1,291,427 I (1) (4) Held by Invemed Catalyst Fund, L.P.
Class A Common Share, $0.01 per share               5,658 I (4) Held by Invemed Securities, Inc.
Class A Common Share, $0.01 per share               44,566 D (4)  

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. SEC 1474 (9-02)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)
6. Date Exercisable and Expiration Date
(Month/Day/Year)
7. Title and Amount of Underlying Securities
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)
11. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares

Reporting Owners

Reporting Owner Name / Address Relationships
 Director  10% Owner  Officer  Other
INVEMED CATALYST FUND LP
375 PARK AVE
STE 2205
NEW YORK, NY 10152
    X   See Remarks
INVEMED CATALYST GENPAR LLC
375 PARK AVE
STE 2205
NEW YORK, NY 10152
    X   See Remarks
GLADWYNE CATALYST GENPAR LLC
645 FIFTH AVENUE
NEW YORK, NY 10022
    X   See Remarks
INVEMED SECURITIES INC
375 PARK AVE
STE 2205
NEW YORK, NY 10152
    X   See Remarks
LANGONE KENNETH G
375 PARK AVENUE
STE 2205
NEW YORK, NY 10152
    X   See Remarks

Signatures

 Invemed Catalyst Fund, L.P. By: Invemed Catalyst GenPar, LLC, its General Partner By: Gladwyne Catalyst GenPar, LLC, Its Managing Member By: /s/ Suzanne Present   11/24/2009
**Signature of Reporting Person Date

 Invemed Catalyst GenPar, LLC By: Gladwyne Catalyst GenPar, LLC, Its Managing Member By: /s/ Suzanne Present   11/24/2009
**Signature of Reporting Person Date

 Gladwyne Catalyst GenPar, LLC By: /s/ Suzanne Present   11/24/2009
**Signature of Reporting Person Date

 Invemed Securities, Inc. By: /s/ John Baron   11/24/2009
**Signature of Reporting Person Date

 /s/ Kenneth G. Langone   11/24/2009
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) Represents shares owned directly by Invemed Catalyst Fund, L.P. (the "Fund"). Invemed Catalyst GenPar, LLC ("Catalyst GenPar") is the general partner of the Fund. Gladwyne Catalyst GenPar, LLC ("Gladwyne GenPar") and Invemed Securities, Inc. ("Invemed") are managing members of Catalyst GenPar. Kenneth G. Langone is the principal stockholder of Invemed. On November 20, 2009, the Fund directed the distribution of an aggregate of 1,291,346 shares of Class A common stock, par value $0.01 per share (the "Common Stock") pro rata to its partners. The shares received by Catalyst GenPar are being further distributed pro rata to its members. No consideration is being paid in connection with the distributions.
(2) Represents shares owned indirectly by Catalyst GenPar and Gladwyne GenPar. Each of Catalyst GenPar and Gladwyne GenPar disclaims beneficial ownership of the shares directly owned by the Fund except to the extent of its pecuniary interest therein.
(3) Represents shares owned directly or indirectly by Invemed, including shares received in the distributions. Invemed disclaims beneficial ownership of shares directly owned by the Fund except to the extent of its pecuniary interest therein.
(4) Represents shares owned directly or indirectly by Kenneth Langone, including shares received in the distributions. Mr. Langone disclaims beneficial ownership of shares directly owned by the Fund except to the extent of his pecuniary interest therein.
 
Remarks:
The Reporting Persons may be deemed to be members of a Section 13(d) group that owned more than 10% of the issuer's
 outstanding shares of Common Stock at the time of the distributions. However, the Reporting Persons disclaim such group
 membership, and this report shall not be deemed an admission that the Reporting Persons are members of a Section 13(d)
 group that owns more than 10% of the issuer's outstanding shares of Common Stock for Section 16 or any other purposes.  As a
 result of the distributions, all of the Reporting Persons ceased to be 10% owners of the issuer's Common Stock.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.